Lead Molecular Biologist - Stevenage, Hertfordshire, United Kingdom - Serna Bio

Description

Serna Bio is building the world's first map of the druggable transcriptome, systematically opening up the universe of RNA biology to small molecule drug discovery.

Using our Discovery Platform, we are tackling the classically intractable targets ranging from coding to non-coding RNA.

We are looking for an Experienced Lead Scientist to join our Stevenage-based R&D lab and contribute to our R&D work.

Working with a small and nimble team, you will help establish novel methodologies, contribute to our commercial objectives and have the opportunity to scale your career as we grow the company.

You'll have plenty of opportunity to grow as a scientist and to expand your talents outside of your current comfort zone.

Design, implement and carry out lab work focused on the development and optimisation of assays
Help us grow, and rapidly grow your career
Own and Deliver projects directly with our R&D team

You will be a key member of our growing UK labs in Stevenage, contributing to a variety of Molecular and cell biology work.

PhD or MSc with at least 2- 5 years experience in a biotech or CRO in Molecular biology,
Demonstrable experience in RNASeq library prep and other NGS methods (Biochemistry, Genomics)
Direct hands-on experience with molecular biology methods (DNA/RNA techniques, cloning, PCR, qPCR, PAGE)
Bonus Skills
~ You are proud of your lab notebooks and your ability to communicate complex ideas simply
Well-developed critical thinking and project management skills
We are data-driven: Data trumps opinions.
The opportunity to accelerate your career. You will have the opportunity to grow your career as we grow our labs
We care deeply about inclusive working practices and diverse teams. Diversity is integral to our success, and an inclusive environment allows the team to do their best work

Serna Bio is building the world's first map of the druggable transcriptome, systematically opening up the universe of RNA biology to small molecule drug discovery.

Using our Discovery Platform, we are tackling the classically intractable targets, with an initial focus on Oncology and Rare Disease.